A 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Amomum villosum extract and Atractylodes macrocephala-extract mixture on decrease of body fat

Wonkwang University. Iksan Korean Medicine Hospital0 个研究点目标入组 120 人开始时间: 待定最近更新: 2021年12月2日

试验速览

暂无简介。

•1) A person whose BMI is 25-34.9 kg/m2, or whose body fat percentage is 25% for men and 30% or more for women at the time of screening test;
•2) A person who has fully understood the detailed explanation of this clinical study, and then agrees to voluntarily decide to participate and observe the precautions.

•(1) A person who has at least 10% weight change within three months before the screening test
•(2) A person who has clinically significant acute or chronic cardiovascular relationships, endocrine systems, immune systems, respiratory systems, hepatic biliary systems, kidneys and urinary systems, neuropsychiatric systems, musculoskeletal systems, inflammatory and hematoplasia, gastrointestinal diseases, etc.
•(3) A fasting implementer.
•(4) A person who has received an antipsychotic medication within three months before the screening test
•(5) A person who participates in another clinical study or plans to participate in the clinical study within three months before the screening test;
•(6) A person who is deemed unsuitable for the person in charge of testing to participate in research due to the results of medical examinations for diagnostic examinations and other reasons

发起方

Wonkwang University. Iksan Korean Medicine Hospital